Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Statement on Nuplazid Drug

On 4/9/18, CNN published an article on the FDA-approved drug, Nuplazid, used to treat hallucinations and psychosis A broad medical term used to describe a loss of contact with reality that involves hallucinations and/or delusions. in Parkinson’s disease. The article investigates FDA data showing the number of reported deaths with people taking Nuplazid. Nuplazid was approved by the FDA in 2016 and is manufactured by Acadia Pharmaceuticals.

The Parkinson’s Foundation is closely monitoring the recent reports on Nuplazid. At this time, we are recommending that patients on this drug consult with their neurologists about the risks and benefits of the treatment. The FDA will continue to monitor the drug’s use and safety, but they have not identified a specific safety issue that isn’t already described in the drug’s label. 

Parkinson’s disease psychosis is typically seen in advanced stages of Parkinson’s disease involving elderly patients. Treating Parkinson’s disease psychosis is a multi-step process that begins with talking to your health care team. They will follow a series of steps to figure out how best to address symptoms. For more information on this topic, please call our toll-free Helpline at 1-800-4PD-INFO (473-4636). 

Please report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1‑800‑FDA‑1088. You can also call ACADIA Pharmaceuticals Inc. at 1‑844‑4ACADIA (1‑844‑422‑2342).

For more information about Psychosis and Parkinson’s Disease:

Listen to our podcast

Read our recent blog article

Read more in our free book, "Psychosis: A Mind Guide to Parkinson's Disease"

Watch our Expert Briefings: Parkinson's Disease Psychosis: Hallucinations, Delusions and Paranoia

Tuesday, April 10, 2018
Parkinson's Disease Foundation Highlights Under-recognized Aspects of Disease with New Online Educational Series
Tuesday, September 15, 2015

The Parkinson's Disease Foundation® (PDF®) is pleased to announce the launch of its latest series of PD ExpertBriefings — six free online seminars designed to shed light on under-recognized aspects of Parkinson's disease. The series, presented by leaders in Parkinson's research and care, begins today, Tuesday, September 15 at 1:00 PM ET.

PDF-Funded Research Paves the Way to Phase III Drug Trial
Wednesday, September 2, 2015

The Parkinson’s Disease Foundation (PDF) is pleased to announce that research initially launched with PDF funding will be tested in a phase III clinical trial A research study in humans that aims to test a new intervention – this could be a drug, surgery or therapy like exercise or diet guidelines – to make sure it is effective a

The National Parkinson Foundation’s Medical Director Publishes New Book on Breakthrough Therapies for Parkinson’s Disease
Monday, August 31, 2015

Sequel to 2013 Bestseller, “Parkinson’s Treatment: 10 Secrets to a Happier Life”

PDF Mourns the Passing of Oliver Sacks
Sunday, August 30, 2015

The Parkinson’s Disease Foundation  (PDF) mourns the loss of neurologist and friend, Oliver Sacks, M.D., (pictured at left), who passed away on August 30th. 

The National Parkinson Foundation Welcomes New Board Member
Friday, August 21, 2015

MIAMI — The National Parkinson Foundation (NPF) announced the election of a new member to its Board of Directors: Dr. Guido Goldman.

The National Parkinson Foundation Launches New and Improved Parkinson.org
Monday, August 3, 2015

Premier website for the Parkinson's disease community

MIAMI — The National Parkinson Foundation announces today the official launch of a redesigned website, www.parkinson.org, devoted to increasing awareness and understanding of Parkinson's disease by offering free resources to people diagnosed with the disease and their families.

NPF Funds Community Research
Monday, June 29, 2015

The National Parkinson Foundation’s Moving Day® Fall 2014 Walks Fund Nearly $1 Million in Parkinson’s Programs

Community Grants Awarded in Atlanta, Boston, Chicago, Los Angeles, Miami and North Carolina

NPF Study Finds that Regular Exercise Can Slow Decline in Quality of Life
Wednesday, June 17, 2015

Data from the Parkinson’s Outcomes Project Presented at the 19th International Congress of Parkinson’s Disease and Movement Disorders

PDF Congratulates New NINDS Director Walter J. Koroshetz, M.D.
Tuesday, June 16, 2015

The Parkinson's Disease Foundation congratulates Walter J. Koroshetz, M.D., on being selected as the Director of the National Institute of Neurological Disorders and Stroke (NINDS). In this role, Dr. Koroshetz assumes oversight of a $1.6 billion budget for scientific research into neurological diseases, including Parkinson’s disease.

PDF Survey Finds Patient Input is Critical to Guiding Parkinson’s Research
Monday, June 15, 2015

Data Presented at 19th Annual International Parkinson and Movement Disorders Society Congress in San Diego, CA - Jun 15 2015

Pages

mail icon

Subscribe here to get the latest news on treatments, research and other updates.